QC CARDIOVASCULAR SYSTEM
QC10 LIPID MODIFYING AGENTS
QC10B LIPID MODIFYING AGENTS, COMBINATIONS
QC10BX Lipid modifying agents in combination with other drugs
QC10BX19 atorvastatin, amlodipine and candesartan
Last updated: 2024-01-17
Postal address:
Norwegian Institute of Public Health
WHO Collaborating Centre for Drug Statistics Methodology
Postboks 222 Skøyen
0213 Oslo
Norway
Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway
Tel: +47 21 07 81 60
E-mail:
Copyright/Disclaimer
Norwegian Institute of Public Health
WHO Collaborating Centre for Drug Statistics Methodology
Postboks 222 Skøyen
0213 Oslo
Norway
Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway
Tel: +47 21 07 81 60
E-mail:
Copyright/Disclaimer